| P50 | author | Luis E. Andrade | Q60611122 |
| | Emilia Sato | Q71523934 |
| P2093 | author name string | M B Ferraz | |
| | E Atra | |
| | I M Meinão | |
| P2860 | cites work | Ophthalmologic safety of long-term hydroxychloroquine treatment | Q28327462 |
| | Chloroquine retinopathy: is there a safe daily dose? | Q28367781 |
| | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
| | Antimalarials in the management of discoid and systemic lupus erythematosus | Q39772563 |
| | Risk/benefit analysis of hydroxychloroquine sulfate treatment in rheumatoid arthritis | Q41920999 |
| | Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials | Q41921005 |
| | Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment | Q41921011 |
| | Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy | Q41921017 |
| | Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids | Q41943371 |
| | Methodology. A study of the single radial hemolysis in gel system. 3. Quantitation of complement | Q47940840 |
| P433 | issue | 3 | |
| P921 | main subject | chloroquine | Q422438 |
| P304 | page(s) | 237-241 | |
| P577 | publication date | 1996-06-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Controlled trial with chloroquine diphosphate in systemic lupus erythematosus | |
| P478 | volume | 5 | |